Pharma conclave 2023
A 2-day virtual event on advancing pharma technology
October 25-26, 2023 | 10:00 a.m. – 1:00 p.m. CET
Are you ready to propel drug development and revolutionize the pharma industry?
On the quest to develop more effective drugs, the synergy between technology providers and scientists is paramount. Together, they generate reliable and reproducible results, accelerating new chemical entities through the pipeline. From research to commercialization, a continuous cycle of tests and workflows shapes the future, determining your success.
Discover new possibilities:
Unlock the potential of cutting-edge technology and master the art of making the right decisions. The 2-day event brings you interactive expert talks, enriching your knowledge and empowering you to embrace innovative techniques that save precious time at work. From the research of new markers to the drug development moving into non and GLP bioanalysis. Plan your next lab expansion with confidence.
Why attend?
- Insightful expert talks: engage with 8 prominent speakers and key opinion leaders in the field
- Explore mass spectrometry in pharma: talks about research and quantitation of biomarkers, characterization of metabolites, drug quantitation and nitrosamine impurities, harness the power of mass spectrometry and plan your lab expansion with confidence
- Collaboration and networking: connect with like-minded professionals, share experiences, and build valuable connections within the industry
- Be the forefront of advancements: stay ahead of the competition by gaining insights into the latest trends and advancements in pharma technology
Remember, SCIEX offers the platform, but it is the experts who take the stage and drive technological progress.
Day 1: Wednesday, October 25
Register now to secure your seat
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:40 | The Echo® MS system, a high throughout mass spectrometry Revolution to accelerate hit finding and drug discovery | Celine Legros and Dany Jeanne Dit Fouque, Eurofins |
| 10:40 - 11:20 | Qualification of lipid biomarker assays using chromatography with triple-quad mass spectrometry | Freddy Oosterbring, Ardena |
| 11:20 - 11:30 | Break | |
| 11:30 - 12:10 | Mass spectrometry, a useful aid in Alzheimer´s disease diagnosis | Jose Antonio Allué, Araclon |
| 12:10 - 12:50 | LC-MS to analyze oligonucleotides: a tool for the characterization of new biotherapeutics | Margalida Artigues, IQS |
| 12:50 - 13:00 | Final notes | Ferran Sanchez, SCIEX |
Day 2: Thursday, October 26
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:40 | Case studies from bioanalytical lab in DMPK, Syngene: SCIEX 7500 system and beyond | Ashwani Gaur, Syngene International Ltd |
| 10:40 - 11:20 | Challenges in quantification of NDSRI’s | Dama Venugopal Rao, Dr. Reddy's Laboratories |
| 11:20 - 11:30 | Break | |
| 11:30 - 12:10 | Nitrosamine impurities in dermal products: from APIs and their salts (secondary amines) evaluations through analytical chemistry and mass spectrometry | Emiliano de Dominicis, Merieux |
| 12:10 - 12:50 | Extractables and leachables assessments in biologics manufacturing | Lukas Mogler, Lonza |
| 12:50 - 13:00 | Final notes | Ferran Sanchez, SCIEX |
Celine Legros
Drug Discovery
Partnership Director, Eurofins Discovery
Celine Legros, PhD, Drug Discovery Partnership Director, is deeply involved in the design of complex projects, including Hit-Finding, Hit-toLead and Lead-Op programs. Prior to joining Eurofins, Dr. Legros was Scientific Project Leader in the Screening Department at the Institut de Recherches Servier, France, where she was involved in neuroscience, cardio-metabolic diseases, immune-inflammation, and oncology projects, from HTS through to Lead-Optimization. Dr. Legros holds a Ph.D. in Animal Physiology (melatonin circanual rhythm and melatonin receptors) from the University of Tours, France, and completed a postdoctoral fellowship at the Blood Brain Barrier Group at King’s College London, UK.
Dany Jeanne Dit Fouque
Development Analytic Engineer,
Eurofins Cerep
Dany Jeanne dit Fouque, PhD, is a Mass Spectrometry Analytical Development Engineer at Eurofins Cerep. He has 7 years of experience in analytical chemistry with in-depth knowledge in UHPLC-MS/MS method development, enzymatic reaction and MS-Binding using mass spectrometry. Prior to joining Eurofins, he worked in the academic sector on several R&D projects to develop and optimize a new methodology using UHPLC-MSn experiments to identify and quantify isomeric/isobaric compounds in mixture. Dr. Jeanne dit Fouque received his Ph.D. in Mass Spectrometry from the University of Brest, France.
Freddy Oosterbring
Senior Scientist, Deputy Director Laboratory
Ardena
Freddy Oostebring, Manager Laboratory section chromatography and mass spectrometry at Ardena Bioanalysis. He holds a bachelor degree in Analytical Chemistry and has been working with triple quad mass spectrometry for more than 20 years. His expertise is in the field of method development for the analysis of small molecules, targeted lipids and peptides in biological matrices. Since 2019, he has been a member of the SCIEX Innovation Advisory Board.
Jose Antonio Allué
Senior Scientist Mass Spectrometry Laboratory, R&D Department
Araclon Biotech S.L.
Ph.D. (Pharmacy) University of Barcelona, Spain.
Twenty-five years in the field of Biological Mass Spectrometry, fifteen of them dedicated to research in Alzheimer´s Disease by HPLC-MS/MS (MALDI, IMS-MS, Orbitrap-MS, reTOF-MS, TOF/TOF-MS, Ion-Trap-MS and Triple Quadrupole-MS). Applications of both, targeted and untargeted, proteomic techniques in the fields of immunology, metabolism, pharmacokinetics and pharmacodynamics. Applications of High-Mass MALDI Mass Spectrometry for the analysis of protein complexes and vaccines. Label-free shotgun proteomics by Travelling Wave Ion Mobility Spectrometry coupled to TOF-MS. Applications of MS to the study of amyloid species in tissues and biofluids, including human, dog and transgenic mice models. Research focus: blood and cerebrospinal fluid amyloid biomarkers in Alzheimer´s Disease. Direct analysis of amyloid peptides in blood without immunoprecipitation enrichment.
Margalida Artigues
Responsable de IQS SCIEX Demo Lab
Instituto Químico de Sarrià IQS
Margalida Artigues earned her Ph.D. in Chemistry in 2019 from Ramon Llull University. She holds a Master's degree in Analytical Chemistry, as well as a Bachelor's degree in Chemistry, both from the same university. Since 2021, she has been leading the Mass Spectrometry Laboratory IQS-SCIEX Demo Lab, based in Barcelona, where she is an integral part of the research team at IQS Tech Transfer. In her current role, her mission is to promote research, facilitate technology transfer, and provide support in educational activities related to the LC-MS analytical technique.
Emiliano de Dominicis
Chemistry Research Director
Mérieux NutriSciences
Emiliano De Dominicis is a researcher with over twenty years of experience in food and pharmaceutical safety, following both private and academic sectors, and he is now Director of Chemical Research - Project Manager at Mérieux NutriSciences. With a Research and Development in Analytical Chemistry dedicated team, Emiliano is responsible for Mérieux NutriSciences Global Research Projects and Scientific Center. Moreover, Emiliano De Dominicis actively participates in funded scientific projects (regional, national and European), scientific congresses as speaker, and writes articles published in specialized scientific journals.
Lukas Mogler
Sr Group Leader, Extractables and Leachables
Lonza DPS
Dr. Lukas Mogler, Sr Group Leader Extractables and Leachables at Lonza DPS Basel Switzerland. He is a graduated diploma pharmacist holding a PhD from University of Freiburg, Germany. Worked in the field of Forensic Toxicology with focus on mass spectrometry and metabolism studies. Joined Lonza DPS in 2020, responsible for extractables and leachables and elemental impurities assessments.
Ashwani Gaur
Senior Principal Scientist, Drug Metabolism and Pharmacokinetics
Syngene international Limited
Ashwani Gaur, is Senior Principal scientist in Drug metabolism and Pharmacokinetics department of Syngene international Limited. Ashwani Joined Bioanalytical team in Ranbaxy research Lab soon after completing MS degree in Pharmaceutical Analysis from National Institute of Pharmaceutical Education and Research, India in 2004. Prior to Syngene, he worked in Advinus Therapeutics and Eurofins. Ashwani has contributed to small molecules drug-discovery projects internally and with large and medium size pharmaceutical companies around the globe specifically in lead identification/optimization stages. He leads a team of experts in LC-MS-based bioanalysis of small molecules, metabolites, prodrugs, biomarkers, complex bioanalysis involving chemical derivitisation and exposure determination new modalities like Protacs, ADC`s, oligonucleotides etc. in multiple biological matrices.